ENVISIA THERAPEUTICS SELECTED TO PRESENT DURING ANTERIOR SEGMENT COMPANY SHOWCASE AT 2016 OPHTHALMALOGY INNOVATION SUMMIT
Company to Highlight Novel Approach to Developing Extended-‐Release Ocular Therapies
RESEARCH TRIANGLE PARK, NC – October 10, 2016 – Envisia Therapeutics today announced that it has been selected to present during the Anterior Segment Company Showcase at the 2016 Ophthalmology Innovation Summit (OIS) being held at 8:30am CDT on October 13, 2016 at the Planet Hollywood Hotel in Chicago, Illinois. Commonly referred to as OIS@AAO, the summit is held each year in conjunction with the American Academy of Ophthalmology (AAO) Annual Meeting to facilitate meaningful interactions and business partnerships between physicians, entrepreneurs, investors and industry executives who are driving ophthalmic innovation. Read more here.